Relationship of uric acid with progression of kidney disease

被引:415
作者
Chonchol, Michel
Shlipak, Michael G.
Katz, Ronit
Sarnak, Mark J.
Newman, Anne B.
Siscovick, David S.
Kestenbaum, Bryan
Carney, Jan Kirk
Fried, Linda F.
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Renal Dis & Hyperten, Denver, CO 80262 USA
[2] Univ Calif San Francisco, Vet Affairs Med Ctr, Gen Internal Med Sect, San Francisco, CA 94143 USA
[3] Univ Washington, Collaborat Hlth Studies Coordinating Ctr, Seattle, WA 98195 USA
[4] Tufts Univ, New England Med Ctr, Dept Med, Boston, MA 02111 USA
[5] Univ Pittsburgh, Sch Med, Dept Epidemiol, Pittsburgh, PA USA
[6] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98195 USA
[7] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98195 USA
[8] Univ Washington, Harborview Med Ctr, Div Nephrol, Seattle, WA 98104 USA
[9] Univ Vermont, Dept Med, Colchester, VT USA
[10] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
关键词
uric acid; kidney function; chronic kidney disease;
D O I
10.1053/j.ajkd.2007.05.013
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Uric acid levels are increased in patients with kidney dysfunction. We tested the hypothesis that uric acid may be associated with kidney disease progression. Study Design: Cohort study. Setting & Participants: 5,808 participants of the Cardiovascular Health Study. Predictor: Uric acid levels. Outcomes & Measurements: Kidney disease progression was defined as a decrease in estimated glomerular filtration rate (GFR) of 3 mL/min/1.73 m(2) per year or greater (>= 0.05 mL/s) and as incident chronic kidney disease (CKD). Measures of kidney function were estimated GFR using the Modification of Diet in Renal Disease Study equation. Results: Higher quintiles of uric acid levels were associated with greater prevalences of estimated GFR less than 60 mL/min/1.73 m(2) (<1.00 mL/s) of 7%, 14%, 12%, 25%, and 42% for quintiles 1 (<= 4.41 mg/dL [:<= 262 mu mol/L]), 2 (4.41 to 5.20 mg/dL [262 to 309 mu mol/L]), 3 (5.21 to 5.90 mg/dL [310 to 351 mu mol/L]), 4 (5.91 to 6.90 mg/dL [352 to 410 mu mol/L]), and 5 (>6.90 mg/dL [>410 mu mol/L]), respectively. In comparison, there was only a modest, but significant, association between quintiles of uric acid levels and progression of kidney function decrease, with adjusted odds ratios of 1.0, 0.88 (95% confidence interval [Cl], 0.64 to 1.21), 1.23 (95% Cl, 0.87 to 1.75), 1.47 (95% Cl, 1.04 to 2.07), and 1.49 (95% Cl, 1.00 to 2.22) for quintiles 1 through 5, respectively. No significant association was found between uric acid level and incident CKID (adjusted odds ratio, 1.00; 95% Cl, 0.89 to 1.14). Limitations: Measurements of albuminuria were not available. Conclusions: Uric acid levels are associated strongly with prevalent CKD. In comparison, greater uric acid levels had a significant, but much weaker, association with progression of kidney disease. Am J Kidney Dis 50:239-247. (c) 2007 by the National Kidney Foundation, Inc.
引用
收藏
页码:239 / 247
页数:9
相关论文
共 34 条
[1]   Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes [J].
Bo, S ;
Cavallo-Perin, P ;
Gentile, L ;
Repetti, E ;
Pagano, G .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2001, 31 (04) :318-321
[2]   HYPERURICEMIA IN PRIMARY AND RENAL HYPERTENSION [J].
CANNON, PJ ;
STASON, WB ;
DEMARTINI, FE ;
SOMMERS, SC ;
LARAGH, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1966, 275 (09) :457-+
[3]  
CUSHMAN M, 1995, CLIN CHEM, V41, P264
[4]   Sevum uric acid and cardiovascular mortality - The NHANES I epidemiologic follow-up study, 1971-1992 [J].
Fang, J ;
Alderman, MH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (18) :2404-2410
[5]   Serum uric acid: A risk factor and a target for treatment? [J].
Feig, Daniel I. ;
Mazzali, Marilda ;
Kang, Duk-Hee ;
Nakagawa, Takahiko ;
Price, Karen ;
Kannelis, John ;
Johnson, Richard J. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (04) :S69-S73
[6]  
FESSEL WJ, 1979, AM J MED, V67, P74, DOI 10.1016/0002-9343(79)90076-7
[7]   Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals [J].
Fried, L ;
Solomon, C ;
Shlipak, M ;
Seliger, S ;
Stehman-Breen, C ;
Bleyer, AJ ;
Chaves, P ;
Furberg, C ;
Kuller, L ;
Newman, A .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (12) :3184-3191
[8]  
Fried Linda P., 1991, Annals of Epidemiology, V1, P263
[9]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[10]  
Iseki K, 2004, AM J KIDNEY DIS, V44, P642, DOI [10.1053/j.ajkd.2004.06.006, 10.1016/S0272-6386(04)00934-5]